{
    "organizations": [],
    "uuid": "f8b81e133de7a18d9a107e9ba4eec1ef75462563",
    "author": "",
    "url": "https://www.reuters.com/article/brief-axsome-therapeutics-announces-firs/brief-axsome-therapeutics-announces-first-patient-enrolled-in-phase-2-clinical-trial-of-axs-05-in-smoking-cessation-idUSASC09WR7",
    "ord_in_thread": 0,
    "title": "BRIEF-Axsome Therapeutics Announces First Patient Enrolled In Phase 2 Clinical Trial Of AXS-05 In Smoking Cessation",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 23, 2018 / 11:50 AM / Updated 9 minutes ago BRIEF-Axsome Therapeutics Announces First Patient Enrolled In Phase 2 Clinical Trial Of AXS-05 In Smoking Cessation Reuters Staff 1 Min Read \nApril 23 (Reuters) - Axsome Therapeutics Inc: \n* AXSOME THERAPEUTICS ANNOUNCES FIRST PATIENT ENROLLED IN PHASE 2 CLINICAL TRIAL OF AXS-05 IN SMOKING CESSATION Source text for Eikon: Further company coverage:",
    "published": "2018-04-23T14:50:00.000+03:00",
    "crawled": "2018-04-23T15:04:50.016+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "announces",
        "first",
        "patient",
        "enrolled",
        "phase",
        "clinical",
        "trial",
        "smoking",
        "cessation",
        "reuters",
        "staff",
        "min",
        "read",
        "april",
        "reuters",
        "axsome",
        "therapeutic",
        "inc",
        "axsome",
        "therapeutic",
        "announces",
        "first",
        "patient",
        "enrolled",
        "phase",
        "clinical",
        "trial",
        "smoking",
        "cessation",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}